Dublin, April 10, 2026 (GLOBE NEWSWIRE)-- The "The Principles & Applications of CRISPR (July 7, 2026)" training has been added to ResearchAndMarkets.com's offering. This course offers an in-depth ...

The type I CRISPR protein Cas3 works like Pac-Man, chomping away at a continuous stream of nucleotides with intrinsic activity for introducing targeted large deletions from a few hundred base pairs to ...

Researchers at Gladstone Institutes (CA, USA) have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify ...

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a ...

Intellia Therapeutics reported that its in vivo CRISPR therapy, lonvo-z, met all primary and secondary endpoints in a Phase 3 trial for hereditary angioedema, with 62% of treated patients attack-free ...

Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat ...

Intellia Therapeutics’ in vivo CRISPR gene therapy, lonvo-z, significantly reduced hereditary angioedema attacks in a Phase III trial, meeting its primary endpoint. Patients receiving the one-time ...

CRISPR is a revolutionary tool that allows scientists to precisely modify the genome and gene expression of cells in any organism. It's a reagent - a substance that facilitates a reaction - that ...

Gene editing is growing up. Ten years after Science magazine named CRISPR its 2015 “Breakthrough of the Year,” this revolutionary gene editing technology has become a workhorse of modern biology. In ...

As translational CRISPR-based research continues to make waves in laboratories and the clinic, scientists across life science disciplines pursue out-of-the-ordinary genome editing applications. From ...